233 related articles for article (PubMed ID: 35719949)
1. Patient-Derived Organoid Serves as a Platform for Personalized Chemotherapy in Advanced Colorectal Cancer Patients.
Geevimaan K; Guo JY; Shen CN; Jiang JK; Fann CSJ; Hwang MJ; Shui JW; Lin HT; Wang MJ; Shih HC; Li AF; Chang SC; Yang SH; Chen JY
Front Oncol; 2022; 12():883437. PubMed ID: 35719949
[TBL] [Abstract][Full Text] [Related]
2. Organoids as a biomarker for personalized treatment in metastatic colorectal cancer: drug screen optimization and correlation with patient response.
Smabers LP; Wensink E; Verissimo CS; Koedoot E; Pitsa KC; Huismans MA; Higuera Barón C; Doorn M; Valkenburg-van Iersel LB; Cirkel GA; Brousali A; Overmeer R; Koopman M; Braat MN; Penning de Vries B; Elias SG; Vries RG; Kranenburg O; Boj SF; Roodhart JM
J Exp Clin Cancer Res; 2024 Feb; 43(1):61. PubMed ID: 38414064
[TBL] [Abstract][Full Text] [Related]
3. Patient-derived organoids as a platform for drug screening in metastatic colorectal cancer.
He X; Jiang Y; Zhang L; Li Y; Hu X; Hua G; Cai S; Mo S; Peng J
Front Bioeng Biotechnol; 2023; 11():1190637. PubMed ID: 37284236
[No Abstract] [Full Text] [Related]
4. "Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction".
Papaccio F; García-Mico B; Gimeno-Valiente F; Cabeza-Segura M; Gambardella V; Gutiérrez-Bravo MF; Alfaro-Cervelló C; Martinez-Ciarpaglini C; Rentero-Garrido P; Zúñiga-Trejos S; Carbonell-Asins JA; Fleitas T; Roselló S; Huerta M; Sánchez Del Pino MM; Sabater L; Roda D; Tarazona N; Cervantes A; Castillo J
J Exp Clin Cancer Res; 2023 Jan; 42(1):8. PubMed ID: 36604765
[TBL] [Abstract][Full Text] [Related]
5. Patient-derived organoid culture of gastric cancer for disease modeling and drug sensitivity testing.
Zu M; Hao X; Ning J; Zhou X; Gong Y; Lang Y; Xu W; Zhang J; Ding S
Biomed Pharmacother; 2023 Jul; 163():114751. PubMed ID: 37105073
[TBL] [Abstract][Full Text] [Related]
6. Colorectal cancer organoid models uncover oxaliplatin-resistant mechanisms at single cell resolution.
Chen G; Gong T; Wang Z; Wang Z; Lin X; Chen S; Sun C; Zhao W; Kong Y; Ai H; Yang H; Liu Y; Wu F; Kang J; Zhao S; Xiao X; Sun J; He A; Li Z
Cell Oncol (Dordr); 2022 Dec; 45(6):1155-1167. PubMed ID: 36136268
[TBL] [Abstract][Full Text] [Related]
7. Interrogating colorectal cancer metastasis to liver: a search for clinically viable compounds and mechanistic insights in colorectal cancer Patient Derived Organoids.
Cioce M; Fumagalli MR; Donzelli S; Goeman F; Canu V; Rutigliano D; Orlandi G; Sacconi A; Pulito C; Palcau AC; Fanciulli M; Morrone A; Diodoro MG; Caricato M; Crescenzi A; Verri M; Fazio VM; Zapperi S; Levrero M; Strano S; Grazi GL; La Porta C; Blandino G
J Exp Clin Cancer Res; 2023 Jul; 42(1):170. PubMed ID: 37460938
[TBL] [Abstract][Full Text] [Related]
8. KLF5 inhibition overcomes oxaliplatin resistance in patient-derived colorectal cancer organoids by restoring apoptotic response.
Shen X; Zhang Y; Xu Z; Gao H; Feng W; Li W; Miao Y; Xu Z; Zong Y; Zhao J; Lu A
Cell Death Dis; 2022 Apr; 13(4):303. PubMed ID: 35379798
[TBL] [Abstract][Full Text] [Related]
9. Patient-Derived Organoid Model in the Prediction of Chemotherapeutic Drug Response in Colorectal Cancer.
Hao M; Cao Z; Wang Z; Xin J; Kong B; Xu J; Zhang L; Chen P
ACS Biomater Sci Eng; 2022 Aug; 8(8):3515-3525. PubMed ID: 35696669
[TBL] [Abstract][Full Text] [Related]
10. Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients.
Ooft SN; Weeber F; Dijkstra KK; McLean CM; Kaing S; van Werkhoven E; Schipper L; Hoes L; Vis DJ; van de Haar J; Prevoo W; Snaebjornsson P; van der Velden D; Klein M; Chalabi M; Boot H; van Leerdam M; Bloemendal HJ; Beerepoot LV; Wessels L; Cuppen E; Clevers H; Voest EE
Sci Transl Med; 2019 Oct; 11(513):. PubMed ID: 31597751
[TBL] [Abstract][Full Text] [Related]
11. CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids.
Gonzalez-Exposito R; Semiannikova M; Griffiths B; Khan K; Barber LJ; Woolston A; Spain G; von Loga K; Challoner B; Patel R; Ranes M; Swain A; Thomas J; Bryant A; Saffery C; Fotiadis N; Guettler S; Mansfield D; Melcher A; Powles T; Rao S; Watkins D; Chau I; Matthews N; Wallberg F; Starling N; Cunningham D; Gerlinger M
J Immunother Cancer; 2019 Apr; 7(1):101. PubMed ID: 30982469
[TBL] [Abstract][Full Text] [Related]
12. Implementing patient derived organoids in functional precision medicine for patients with advanced colorectal cancer.
Cartry J; Bedja S; Boilève A; Mathieu JRR; Gontran E; Annereau M; Job B; Mouawia A; Mathias P; De Baère T; Italiano A; Besse B; Sourrouille I; Gelli M; Bani MA; Dartigues P; Hollebecque A; Smolenschi C; Ducreux M; Malka D; Jaulin F
J Exp Clin Cancer Res; 2023 Oct; 42(1):281. PubMed ID: 37880806
[TBL] [Abstract][Full Text] [Related]
13. Patient-Derived Organoids from Colorectal Cancer with Paired Liver Metastasis Reveal Tumor Heterogeneity and Predict Response to Chemotherapy.
Mo S; Tang P; Luo W; Zhang L; Li Y; Hu X; Ma X; Chen Y; Bao Y; He X; Fu G; Xu X; Rao X; Li X; Guan R; Chen S; Deng Y; Lv T; Mu P; Zheng Q; Wang S; Liu F; Li Y; Sheng W; Huang D; Hu C; Gao J; Zhang Z; Cai S; Clevers H; Peng J; Hua G
Adv Sci (Weinh); 2022 Nov; 9(31):e2204097. PubMed ID: 36058001
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic Cancer Patient-derived Organoids Can Predict Response to Neoadjuvant Chemotherapy.
Demyan L; Habowski AN; Plenker D; King DA; Standring OJ; Tsang C; St Surin L; Rishi A; Crawford JM; Boyd J; Pasha SA; Patel H; Galluzzo Z; Metz C; Gregersen PK; Fox S; Valente C; Abadali S; Matadial-Ragoo S; DePeralta DK; Deutsch GB; Herman JM; Talamini MA; Tuveson DA; Weiss MJ
Ann Surg; 2022 Sep; 276(3):450-462. PubMed ID: 35972511
[TBL] [Abstract][Full Text] [Related]
15. Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy.
Ubink I; Bolhaqueiro ACF; Elias SG; Raats DAE; Constantinides A; Peters NA; Wassenaar ECE; de Hingh IHJT; Rovers KP; van Grevenstein WMU; Laclé MM; Kops GJPL; Borel Rinkes IHM; Kranenburg O
Br J Surg; 2019 Sep; 106(10):1404-1414. PubMed ID: 31197820
[TBL] [Abstract][Full Text] [Related]
16. Genomic characteristics and drug screening among organoids derived from non-small cell lung cancer patients.
Chen JH; Chu XP; Zhang JT; Nie Q; Tang WF; Su J; Yan HH; Zheng HP; Chen ZX; Chen X; Song MM; Yi X; Li PS; Guan YF; Li G; Deng CX; Rosell R; Wu YL; Zhong WZ
Thorac Cancer; 2020 Aug; 11(8):2279-2290. PubMed ID: 32633046
[TBL] [Abstract][Full Text] [Related]
17. Patient-Derived Organoids Can Guide Personalized-Therapies for Patients with Advanced Breast Cancer.
Chen P; Zhang X; Ding R; Yang L; Lyu X; Zeng J; Lei JH; Wang L; Bi J; Shao N; Shu D; Wu B; Wu J; Yang Z; Wang H; Wang B; Xiong K; Lu Y; Fu S; Choi TK; Lon NW; Zhang A; Tang D; Quan Y; Meng Y; Miao K; Sun H; Zhao M; Bao J; Zhang L; Xu X; Shi Y; Lin Y; Deng C
Adv Sci (Weinh); 2021 Nov; 8(22):e2101176. PubMed ID: 34605222
[TBL] [Abstract][Full Text] [Related]
18. Establishment of patient-derived organoids and a characterization-based drug discovery platform for treatment of pancreatic cancer.
Watanabe S; Yogo A; Otsubo T; Umehara H; Oishi J; Kodo T; Masui T; Takaishi S; Seno H; Uemoto S; Hatano E
BMC Cancer; 2022 May; 22(1):489. PubMed ID: 35505283
[TBL] [Abstract][Full Text] [Related]
19. Patient-derived organoids of non-small cells lung cancer and their application for drug screening.
Li YF; Gao Y; Liang BW; Cao XQ; Sun ZJ; Yu JH; Liu ZD; Han Y
Neoplasma; 2020 Mar; 67(2):430-437. PubMed ID: 31973535
[TBL] [Abstract][Full Text] [Related]
20. Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer.
Tiriac H; Belleau P; Engle DD; Plenker D; Deschênes A; Somerville TDD; Froeling FEM; Burkhart RA; Denroche RE; Jang GH; Miyabayashi K; Young CM; Patel H; Ma M; LaComb JF; Palmaira RLD; Javed AA; Huynh JC; Johnson M; Arora K; Robine N; Shah M; Sanghvi R; Goetz AB; Lowder CY; Martello L; Driehuis E; LeComte N; Askan G; Iacobuzio-Donahue CA; Clevers H; Wood LD; Hruban RH; Thompson E; Aguirre AJ; Wolpin BM; Sasson A; Kim J; Wu M; Bucobo JC; Allen P; Sejpal DV; Nealon W; Sullivan JD; Winter JM; Gimotty PA; Grem JL; DiMaio DJ; Buscaglia JM; Grandgenett PM; Brody JR; Hollingsworth MA; O'Kane GM; Notta F; Kim E; Crawford JM; Devoe C; Ocean A; Wolfgang CL; Yu KH; Li E; Vakoc CR; Hubert B; Fischer SE; Wilson JM; Moffitt R; Knox J; Krasnitz A; Gallinger S; Tuveson DA
Cancer Discov; 2018 Sep; 8(9):1112-1129. PubMed ID: 29853643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
